These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10123075)

  • 1. Institutional Review Board policies and procedures provide protection for human research subjects and hospitals.
    Reynolds MB
    Health Care Law Newsl; 1992 Sep; 7(9):7-11. PubMed ID: 10123075
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Final rule.
    Fed Regist; 1991 Jun; 56(117):28025-9. PubMed ID: 10112215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of human subjects: Institutional Review Board; report and recommendations of National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.
    Fed Regist; 1978 Nov; 43(231):56173-98. PubMed ID: 10239683
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Proposed rule.
    Fed Regist; 1988 Nov; 53(218):45678-82. PubMed ID: 10290533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IRB as deputy sheriff: proposed FDA regulation of the institutional review board.
    Huff TA
    Clin Res; 1979 Apr; 27(2):103-8. PubMed ID: 10241072
    [No Abstract]   [Full Text] [Related]  

  • 6. Protecting and informing human research subjects.
    Check WA
    JAMA; 1980 May 23-30; 243(20):1985-6, 1988, 1993. PubMed ID: 7373734
    [No Abstract]   [Full Text] [Related]  

  • 7. Protecting "human guinea pigs".
    Thompson RC
    FDA Consum; 1986 Dec-1987 Jan; 20(10):12-5. PubMed ID: 10311766
    [No Abstract]   [Full Text] [Related]  

  • 8. Institutional review boards and bioethics committees: their role in ensuring ethical home care research.
    Cary AH
    Home Care Econ; 1987; 1(4):113-8. PubMed ID: 10285378
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential liability for institutional review boards and bioethics committees.
    Reider A
    Home Care Econ; 1987; 1(4):119-21. PubMed ID: 10285379
    [No Abstract]   [Full Text] [Related]  

  • 10. Tales of informed consent: four years on an institutional review board.
    Bartolo
    Health Matrix Clevel; 1992; 2(2):193-245. PubMed ID: 10124879
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical devices; procedures for investigational device exemptions--Food and Drug Administration. Final rule.
    Fed Regist; 1980 Jan; 45(13):3732-59. PubMed ID: 10248822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory overview: protection of human subjects--IRBS and informed consent.
    Nightingale SL
    Drug Inf J; 1987; 21(2):109-15. PubMed ID: 10282111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing caution & courage. Physicians and regulators weigh informed consent issues in clinical research.
    Montague J
    Hosp Health Netw; 1994 Sep; 68(18):50, 52-4. PubMed ID: 8081420
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical lasers and the law.
    Norton ML; Norton EV
    Leg Med; 1986; ():134-47. PubMed ID: 3312887
    [No Abstract]   [Full Text] [Related]  

  • 15. Standards for institutional review boards for clinical investigations: proposed establishment of regulations.
    Fed Regist; 1978 Aug; 43(153):5185-208. PubMed ID: 10237259
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges in human subject protection.
    Nightingale SL
    Food Drug Law J; 1995; 50(4):493-501. PubMed ID: 10343016
    [No Abstract]   [Full Text] [Related]  

  • 17. Research activities which may be reviewed through expedited review procedures set forth in HHS regulations for protection of human research subjects--Department of Health and Human Services. Notice.
    Fed Regist; 1981 Jan; 46(16 Pt 2):8392. PubMed ID: 10249933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Position statement of the AFCR on the issue of regulation of institutional review boards by the FDA.
    Clin Res; 1979 Apr; 27(2):109-11. PubMed ID: 10241073
    [No Abstract]   [Full Text] [Related]  

  • 19. Research and experimentation in hospitals.
    Bernstein AH
    Hospitals; 1979 Oct; 53(19):58, 60, 64 passim. PubMed ID: 468176
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA overview and current challenges in regulation of human subject protection. Food and Drug Administration.
    Nightingale SL
    J Int Assoc Physicians AIDS Care; 1997 Jan; 3(1):24-6. PubMed ID: 11363959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.